Timely detection and response prevented further spread and development of a circulating VDPV type 1 (cVDPV1) and rapidly raised population immunity in a low-coverage area through a high-quality SIA and interrupted spread of the virus.
Abstract
Background
In September 2024, a 4-month-old infant in Liangshan, Sichuan, China was diagnosed with paralytic poliomyelitis that turned out to have been caused by a vaccine-derived poliovirus type 1 (VDPV1). This was the third VDPV outbreak detected by routine acute flaccid paralysis (AFP) surveillance in Sichuan since 2012. We conducted an epidemiological investigation into the event and implemented response measures to prevent further viral spread.
Methods
The investigation and response were conducted according to World Health Organization (WHO) and China's National Health Commission standard operating procedures. Measures included case and virus verification; search for poliovirus among contacts, healthy children, and in wastewater; active surveillance for AFP cases in health facilities and communities; vaccination coverage assessment; and supplementary immunization activity (SIA) and catch-up vaccination.
Results
The paralyzed infant was determined to be a VDPV1 case by the Sichuan provincial expert group; the VDPV1 had 10-15 nucleotide changes from Sabin strain type 1. No VDPVs were found in close contacts, healthy children, or wastewater; no AFP cases were found in health facilities or communities; no local circulation of the VDPV1 was detected. Following a county-wide SIA with catch-up vaccination, 2-dose, bivalent live attenuated polio vaccine coverage was 95.4% among children four months to four years of age, and full-series polio vaccine coverage was 98.5% in children 5-14 years of age.
Conclusions
The VDPV was an ambiguous VDPV type 1 (aVDPV1). Timely detection and response prevented further spread and development of a circulating VDPV type 1 (cVDPV1). Low vaccination coverage and poor sanitation were contributing factors to the emergence of the aVDPV1. Information technology facilitated the strategy of "Government Locates, Health Vaccinates" that rapidly raised population immunity in a low-coverage area through a high-quality SIA and interrupted spread of the virus.
CLINICAL TRIAL NUMBER
Not applicable.
The resurgence of WPV1 in polio-free regions in Afghanistan and Pakistan and the spread of cVDPVs challenge global polio eradication, highlighting the need for rapid detection, expanded nOPV2 use in areas with prolonged transmission, and sustained partner engagement and strategic resource allocation amid declining glob...
H. Whitmire, M. Z. Wadood, Ina G. Storm et al.· Archives of Public Health· 0 citations
The cVDPV1 outbreak in Madagascar demonstrated the potential for significant adult involvement and high mortality in polio outbreaks, and highlighted the importance of inclusive vaccination strategies and tailored approaches in similar settings.
Kpandja Djawe, Eric Aigbogun, Joseph Souba Zoumanigui et al.· Vaccine· 0 citations
BACKGROUND
In 2023, novel oral polio vaccine type 2 (nOPV2) was used to respond to an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Kenya. We assessed the immunogenicity of one and two doses of nOPV2 administered during outbreak response.
METHODS
An observational cohort study was conducted fro...
A. Anand, Damaris Jepkosgei, C. Mwachari et al.· Vaccine· 0 citations
The coronavirus disease 2019, or COVID-19, was named the disease by the World Health Organization and poses a significant threat to public health, including Malaysia, and poses a significant threat to public health, including Malaysia.
Maznieda Mahjom, Imanul Hassan Abdul Shukor, M. Arip et al.· International Journal of Tel...· 0 citations
BACKGROUND
Meningococcal meningitis remains a major public health challenge in Africa's meningitis belt despite the successful elimination of serogroup A epidemics following MenAfriVac introduction. Outbreaks caused by serogroups C, W, and X persist. NmCV-5, a pentavalent conjugate vaccine targeting serogroups A, C, W,...
Laura V Cooper, Médard Djedanem, Assan Abdoul Nasser et al.· Vaccine· 0 citations
Although the immunization program requires OPV vaccine for every infant, outbreaks of polio and Acute Flaccid Paralysis (AFP) still occur frequently, triggering a rapid response of mass immunization. The vaccine of Inactivated Polio Virus (IPV) was added to prevent wild poliovirus which causes paralysis, but its effect...
T. Hardiyanti, Ayun Sriatmi, Martini et al.· Jurnal kesehatan masyarakat· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.